Search results
Genetics in Hypertrophic Cardiomyopathy
Author(s):
María Noël Brögger
,
Ivonne Johana Cárdenas Reyes
,
Soledad García Hernández
,
et al
Added:
1 month ago
Review Article
Cardiomyopathy and Gender Disparities in South Asia
Author(s):
Khalida Soomro
,
David Tak Wai Lui
,
Rungroj Krittayaphong
,
et al
Added:
4 months ago
Review Article
Author(s):
Emily Li-Wen Chu
,
Daniel Seung Kim
,
Ahmad Masri
Added:
5 months ago
Author(s):
Ahmad Masri
Added:
6 months ago
HFSA 2025 - Post hoc analysis of ATTRibute-CM reveals significant reduction in cardiovascular mortality and death after 30 months of acoramidis in patients with ATTR-CM.Dr Ahmad Masri (Oregon Health & Science University, US) joins us to discuss a post hoc exploratory analysis from the ATTRibute-CM trial examining the timing and magnitude of cardiovascular outcome reductions with acoramidis in…
View more
Author(s):
Anjali T Owens
Added:
6 months ago
Navigate the rapidly evolving treatment landscape for hypertrophic cardiomyopathy with Dr Anjali Tiku Owens, a renowned expert in inherited cardiovascular diseases and advanced heart failure.This comprehensive presentation, part of the Cardiomyopathies track of Women As One's CLIMB® 2025 Skills Training Program, explores both established and emerging therapeutic approaches for obstructive and non…
View more
Author(s):
Sara Saberi
Added:
6 months ago
Master the diagnostic complexities of hypertrophic cardiomyopathy (HCM) with Dr Sara Saberi, a leading expert in inherited cardiovascular diseases.This comprehensive presentation, part of the Cardiomyopathies track of Women As One's CLIMB® 2025 Skills Training Program, provides essential insights into the nuanced approach required for accurate HCM diagnosis and risk stratification.Dr Saberi…
View more
Heart Failure in Hypertrophic Cardiomyopathy
Author(s):
Olives Nguyen
,
Daniel Kamna
,
Ahmad Masri
Added:
1 month ago
Review Article
An Expert Assessment on the True Impact of ATTR-CM
Video Series
Author(s):
Marianna Fontana
Added:
1 year ago
AHA Conference 2024 - Safety and efficacy outcomes of nexiguran ziclumeran (NTLA-2001) in patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM).Dr Marianna Fontana (University College London, London, UK) joins us onsite at AHA Conference to discuss the findings from the nexiguran ziclumeran for ATTR-CM trial (NCT04601051).Dr Fontana discusses a phase 1, ongoing, open-label, single…
View more
Author(s):
Michelle Kittleson
Added:
8 months ago
Learn about the management of HFrEF and HFpEF from Dr Michelle Kittleson (Cedars-Sinai Heart Institute, Los Angeles, US).This two-part video lecture series, part of Women As One's CLIMB® 2025 Skills Training Program, provides a comprehensive overview of key treatments and therapy approaches to cardiomyopathies.In this lecture, Dr Kittleson provides an in-depth review of the management of HFrEF…
View more
